Jazz Pharmaceuticals PLC (NAS:JAZZ)
$ 109.74 -2.27 (-2.03%) Market Cap: 6.92 Bil Enterprise Value: 11.03 Bil PE Ratio: 22.63 PB Ratio: 1.87 GF Score: 78/100

Jazz Pharmaceuticals PLC at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript

May 12, 2020 / 07:00PM GMT
Release Date Price: $113.9 (-0.37%)
Operator

Hello. This webcast presentation is for Bank of America clients only. If you are a member or representative of the press or media, please disconnect now. And now I would like to turn the call over to the moderator. Thank you very much, and have a good day.

Jason Matthew Gerberry
BofA Merrill Lynch, Research Division - MD in US Equity Research

Thank you, and good day, everybody, and thanks for joining us for our next company presenter. I'm pleased to be joined by Jazz Pharmaceuticals and CEO, Bruce Cozadd; and CFO, Renée Galá. Thank you both for joining us at our virtual Las Vegas conference, which doesn't sound nearly as exciting as it sounds. But thank you both for joining us.

Bruce C. Cozadd
Jazz Pharmaceuticals plc - Co-Founder, Chairman & CEO

Yes. Happy to be here, Jason.

RenÃ;e D. GalÃ;Jazz Pharmaceuticals plc;Executive VP;CFO;Jason Matthew Gerberry
BofA

©¡,-&

Thank you.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot